OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Publication Date
Release Date
2015
(3)
2023
(1)
2021
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck.
Not available
S-EPMC4600191
|
biostudies-literature
Cite
Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer.
Not available
S-EPMC4600190
|
biostudies-literature
Cite
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Not available
S-EPMC4486342
|
biostudies-literature
Cite
Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Not available
S-EPMC10631452
|
biostudies-literature
Cite
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Not available
S-EPMC7946781
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets